{"component": "definition", "props": {"groups": [{"size": 235, "samples": [{"hash": "k9JtXj6jx7k", "uri": "/contracts/k9JtXj6jx7k#pmda", "label": "Asset Purchase Agreement (MedTech Acquisition Corp)", "score": 34.3004798889, "published": true}, {"hash": "d5ao2dNOi8b", "uri": "/contracts/d5ao2dNOi8b#pmda", "label": "License Agreement (Roivant Sciences Ltd.)", "score": 32.4962348938, "published": true}, {"hash": "4KisrVBsCUe", "uri": "/contracts/4KisrVBsCUe#pmda", "label": "License Agreement (Roivant Sciences Ltd.)", "score": 32.4962348938, "published": true}], "snippet_links": [{"key": "medical-devices", "type": "clause", "offset": [34, 49]}, {"key": "successor-entity", "type": "definition", "offset": [64, 80]}], "snippet": "means Japan\u2019s Pharmaceuticals and Medical Devices Agency or any successor entity thereto.", "hash": "57ec0cb1c42a5f372e27d979da800b66", "id": 1}, {"size": 56, "samples": [{"hash": "5pan4XTdwta", "uri": "/contracts/5pan4XTdwta#pmda", "label": "Evaluation Agreement (Fibrogen Inc)", "score": 35.5954818726, "published": true}, {"hash": "5dYzSOLQHiM", "uri": "/contracts/5dYzSOLQHiM#pmda", "label": "License Agreement (VYNE Therapeutics Inc.)", "score": 34.6153335571, "published": true}, {"hash": "b05pCAA0bJj", "uri": "/contracts/b05pCAA0bJj#pmda", "label": "Evaluation Agreement (Fibrogen Inc)", "score": 34.5961685181, "published": true}], "snippet_links": [{"key": "medical-devices", "type": "clause", "offset": [34, 49]}], "snippet": "means Japan\u2019s Pharmaceuticals and Medical Devices Agency and any successor agency(ies) or authority having substantially the same function.", "hash": "37d9fe344b590c8f6780963eb0edfbaf", "id": 2}, {"size": 52, "samples": [{"hash": "4fBWihDWElc", "uri": "/contracts/4fBWihDWElc#pmda", "label": "Exclusive Research Collaboration, Option and License Agreement (Silence Therapeutics PLC)", "score": 34.1991767883, "published": true}, {"hash": "kWk1ab86y5e", "uri": "/contracts/kWk1ab86y5e#pmda", "label": "Exclusive Research Collaboration, Option and License Agreement (Silence Therapeutics PLC)", "score": 33.2053375244, "published": true}, {"hash": "9a0d3wG9MmY", "uri": "/contracts/9a0d3wG9MmY#pmda", "label": "Exclusive Research Collaboration, License and Option Agreement (LogicBio Therapeutics, Inc.)", "score": 32.603012085, "published": true}], "snippet_links": [{"key": "medical-devices", "type": "clause", "offset": [34, 49]}, {"key": "successor-agency", "type": "definition", "offset": [65, 81]}], "snippet": "means Japan\u2019s Pharmaceuticals and Medical Devices Agency and any successor agency or authority having substantially the same function.", "hash": "86bb18ae96c79b255f5f9a86f7a22763", "id": 3}, {"size": 16, "samples": [{"hash": "83WWYAOgLcb", "uri": "/contracts/83WWYAOgLcb#pmda", "label": "Collaboration and License Agreement (Kymera Therapeutics, Inc.)", "score": 35.1409988403, "published": true}, {"hash": "l3SeuC4QJiw", "uri": "/contracts/l3SeuC4QJiw#pmda", "label": "Collaboration and License Agreement (Kymera Therapeutics, Inc.)", "score": 34.1444206238, "published": true}, {"hash": "3ebf1sSqNAi", "uri": "/contracts/3ebf1sSqNAi#pmda", "label": "Collaboration and License Agreement (Kymera Therapeutics, Inc.)", "score": 31.5790557861, "published": true}], "snippet_links": [{"key": "medical-devices", "type": "clause", "offset": [30, 45]}, {"key": "successor-entity", "type": "definition", "offset": [61, 77]}], "snippet": "means the Pharmaceuticals and Medical Devices Agency and any successor entity thereto.", "hash": "bbac24a94fb0f23686bbfacce889b748", "id": 4}, {"size": 15, "samples": [{"hash": "1CXq3EVYdmD", "uri": "/contracts/1CXq3EVYdmD#pmda", "label": "Intellectual Property License Agreement (Tempus AI, Inc.)", "score": 35.4257354736, "published": true}, {"hash": "vKbSeuMp8m", "uri": "/contracts/vKbSeuMp8m#pmda", "label": "Merger Agreement (Innovate Biopharmaceuticals, Inc.)", "score": 31.3381252289, "published": true}, {"hash": "i7dYa1ymtu1", "uri": "/contracts/i7dYa1ymtu1#pmda", "label": "License Agreement (ADC Therapeutics SA)", "score": 31.2053394318, "published": true}], "snippet_links": [{"key": "medical-devices", "type": "clause", "offset": [39, 54]}, {"key": "successor-agency", "type": "definition", "offset": [70, 86]}], "snippet": "means the Japanese Pharmaceuticals and Medical Devices Agency, or any successor agency thereto.", "hash": "335ccf2c91bc6b1d12723a95a8d5629e", "id": 5}, {"size": 11, "samples": [{"hash": "dMhGqmjMohK", "uri": "/contracts/dMhGqmjMohK#pmda", "label": "Collaboration Agreement (Akebia Therapeutics, Inc.)", "score": 33.1615333557, "published": true}, {"hash": "6LTI7BT6Bmw", "uri": "/contracts/6LTI7BT6Bmw#pmda", "label": "Royalty Interest Acquisition Agreement (Akebia Therapeutics, Inc.)", "score": 30.3538665771, "published": true}, {"hash": "gtjZezxW4V7", "uri": "/contracts/gtjZezxW4V7#pmda", "label": "Collaboration Agreement (Akebia Therapeutics, Inc.)", "score": 27.1984939575, "published": true}], "snippet_links": [{"key": "medical-devices", "type": "clause", "offset": [30, 45]}, {"key": "marketing-authorization-application", "type": "definition", "offset": [125, 160]}, {"key": "and-monitoring", "type": "clause", "offset": [181, 195]}], "snippet": "means the Pharmaceuticals and Medical Devices Agency in Japan or any successor thereto, which conducts scientific reviews of marketing authorization application for pharmaceuticals and monitoring of their post-marketing safety in Japan.", "hash": "e4c6c403345d76cf81521891b0f9410b", "id": 6}, {"size": 9, "samples": [{"hash": "fvCiAq09MQP", "uri": "/contracts/fvCiAq09MQP#pmda", "label": "Commercialization and Distribution Agreement (Capricor Therapeutics, Inc.)", "score": 34.2046546936, "published": true}, {"hash": "cNeEjE30FXy", "uri": "/contracts/cNeEjE30FXy#pmda", "label": "License Agreement (BridgeBio Pharma, Inc.)", "score": 30.8507862091, "published": true}, {"hash": "adetwWK3Xuv", "uri": "/contracts/adetwWK3Xuv#pmda", "label": "License Agreement (Eidos Therapeutics, Inc.)", "score": 30.8288841248, "published": true}], "snippet_links": [{"key": "medical-devices", "type": "clause", "offset": [39, 54]}], "snippet": "means the Japanese Pharmaceuticals and Medical Devices Agency, and local counterparts thereto, and any successor agency(ies) or authority thereto having substantially the same function.", "hash": "16fc2462aab82acd42cc75084b982475", "id": 7}, {"size": 8, "samples": [{"hash": "lmQmB68c4l7", "uri": "https://mlaem.fs.ml.com/content/dam/ML/ipo/equity_new_issues/Certara-Preliminary-Prospectus-Common-Stock-Bookmarked-eRed.pdf", "label": "mlaem.fs.ml.com", "score": 10.9315538406, "published": false}, {"hash": "d5x4Qg3jIBM", "uri": "https://www.stifel.com/prospectusfiles/PD_4583.pdf", "label": "www.stifel.com", "score": 10.8494186401, "published": false}, {"hash": "55YWd9OZAa8", "uri": "https://www.stifel.com/prospectusfiles/PD_4438.pdf", "label": "www.stifel.com", "score": 10.6153316498, "published": false}], "snippet_links": [{"key": "medical-devices", "type": "clause", "offset": [30, 45]}], "snippet": "means the Pharmaceuticals and Medical Devices Agency of Japan;", "hash": "8b2962893b1848b9a31818bcf61e0cfa", "id": 8}, {"size": 7, "samples": [{"hash": "k35hIrs6tN0", "uri": "/contracts/k35hIrs6tN0#pmda", "label": "Contract Research and License Agreement (Merus N.V.)", "score": 31.835729599, "published": true}, {"hash": "3AMOlgVPYiJ", "uri": "/contracts/3AMOlgVPYiJ#pmda", "label": "Contract Research and License Agreement", "score": 31.3408622742, "published": true}, {"hash": "3VJcas76X8S", "uri": "/contracts/3VJcas76X8S#pmda", "label": "Contract Research and License Agreement (Merus N.V.)", "score": 29.3258037567, "published": true}], "snippet_links": [{"key": "medical-devices", "type": "clause", "offset": [30, 45]}, {"key": "regulatory-agency", "type": "definition", "offset": [65, 82]}, {"key": "working-together", "type": "definition", "offset": [84, 100]}, {"key": "ministry-of-health", "type": "definition", "offset": [106, 124]}, {"key": "and-welfare", "type": "clause", "offset": [133, 144]}, {"key": "obligation-to-protect", "type": "clause", "offset": [154, 175]}, {"key": "public-health", "type": "definition", "offset": [180, 193]}], "snippet": "means the Pharmaceuticals and Medical Devices Agency, a Japanese regulatory agency, working together with Ministry of Health, Labour and Welfare with the obligation to protect the public health by assuring safety, efficacy and quality of pharmaceuticals and medical devices.", "hash": "d3b58aeb1ad5e61db6b42cc56649cee3", "id": 9}, {"size": 6, "samples": [{"hash": "hSqIevZvHog", "uri": "/contracts/hSqIevZvHog#pmda", "label": "Development and Commercialization License Agreement (Opko Health, Inc.)", "score": 31.5790557861, "published": true}, {"hash": "hsUBC5zY0mi", "uri": "/contracts/hsUBC5zY0mi#pmda", "label": "Development and Commercialization License Agreement", "score": 30.285150528, "published": true}, {"hash": "iHujitBxc5q", "uri": "/contracts/iHujitBxc5q#pmda", "label": "Development and Commercialization License Agreement (Opko Health, Inc.)", "score": 26.1553726196, "published": true}], "snippet_links": [{"key": "medical-devices", "type": "clause", "offset": [30, 45]}, {"key": "successor-agency", "type": "definition", "offset": [68, 84]}], "snippet": "means the Pharmaceuticals and Medical Devices Agency, Japan and any successor agency or authority thereto.", "hash": "f7738f188fb2ed3c2321f8284f79ea9f", "id": 10}], "next_curs": "ClESS2oVc35sYXdpbnNpZGVyY29udHJhY3Rzci0LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiINcG1kYSMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"size": 461, "title": "PMDA", "snippet": "means Japan\u2019s Pharmaceuticals and Medical Devices Agency or any successor entity thereto.", "id": "pmda", "examples": ["To the extent Kaken reasonably determines it is required for Kaken to comply with <strong>PMDA</strong> requirements or other applicable Laws in the Kaken Territory in connection with Kaken\u2019s activities under this Agreement with respect to Licensed Products, Kaken will have the right, upon reasonable advance written notice, to audit, inspect, and copy all such Development Records and Manufacturing Records that is Controlled by Astria.", "All such responses will be made in accordance with the procedures established pursuant to ICH, FDA, EMA, <strong>PMDA</strong>, and other applicable guidelines."], "related": [["cfda", "CFDA", "CFDA"], ["mfda", "MFDA", "MFDA"], ["mhlw", "MHLW", "MHLW"], ["emea", "EMEA", "EMEA"], ["fda", "FDA", "FDA"]], "related_snippets": [], "updated": "2026-04-02T05:49:26+00:00"}, "json": true, "cursor": ""}}